About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT07069387

Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence

The gold standard for tuberculosis (TB) treatment support requires directly observed therapy (DOT), which means a trained health worker observes the patient swallow each dose of medication every day f...

Lead sponsor: University of Malaya•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Hui Moon Koh

CONTACT

+60183926328 kohhuimoon@moh.gov.my

Reena Rajasuriar

CONTACT

reena@um.edu.my

Sponsors

Lead Sponsor

University of Malaya

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Microbiologically confirmed pulmonary TB (smear- or culture-positive PTB)
•2. 18 years old or older
•3. Able to give consent and physically able to participate in the study
•4. Own a video-recording device with internet connectivity
•5. Within the first 3 weeks of intensive phase TB treatment

Exclusion Criteria

•1. Complicated TB disease including TB meningitis, TB bone/joint, and disseminated TB with planned treatment duration of 9 to 12 months.
•2. Confirmed or suspected drug-resistant (DR)-TB
•3. Documented cognitive, motor, or visual disability that will hinder video device use and lack assistance of a caretaker
•4. Receiving injectable anti-TB drugs
•5. Incarceration or other involuntary detention

Related studies

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

NCT06272812 · Tuberculosis (TB)

RECRUITINGPhase 2

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

NCT07303699 · Pulmonary Tuberculosis (TB)

ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients

NCT06796647 · Tuberculosis (TB)

PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment

NCT07024836 · Tuberculosis (TB)

Examining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial

NCT06916962 · Tuberculosis (TB)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 16, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment160

Start dateApr 2025

Last updatedJul 16, 2025

Condition

Tuberculosis (TB)

Locations shown

Sungai Buloh Hospital

Sungai Buloh, Selangor

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions